Similar Posts
Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?
Protagonist Therapeutics, Inc.(XNAS:PGTX) is a biopharmaceutical company that discovers and develops peptide based therapeutic drugs to address hematology and blood disorders, as well as inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 antagonist peptide, which is currently in Phase II clinical trials for the treatment of inflammatory bowel disease (IBD); and PN-235, an interleukin-23 receptor antagonist for the treatment of both IBD and non-IBD indications. A license and collaboration agreement has been signed between the company and Janssen Biotech Inc.
Fox Corporation: Evaluating News Dominance, Sports Rights, and Streaming Expansion
Fox Corporation is a media company focused primarily on live news, sports broadcasting, and television entertainment, generating revenue through advertising, affiliate fees, and content licensing.
CIBC (TSX: CM) – Prominent Canadian bank, recommended for investment
The Canadian Imperial Bank of Commerce (TSX: CM), founded on June 1, 1961, is a prominent financial institution headquartered in Toronto, Canada. Operating across multiple segments, CIBC provides a comprehensive suite of banking and wealth management services to a diverse clientele. Its business segments include Canadian Personal and Business Banking, Canadian Commercial Banking and Wealth Management, U.S. Commercial Banking and Wealth Management, Capital Markets and Direct Financial Services, and Corporate and Other.
Brookfield Renewable Corporation: Why Combining BEP and BEPC is a Game Changer for Retail Investors
Company Overview Ticker: BEPC(NYSE) Headquarters: New York, USA Founded: 2019 CEO: Connor David Teskey Industry: Electric Utilities Core Business Brookfield Renewable operates a diversified portfolio spanning renewable power generation, energy storage, and sustainable solutions. Hydroelectric Power Hydropower remains the company's…This report is available to MarketFacts members.Log in to read this report
DuPont de Nemours, Inc. (NYSE: DD): A Timeless Investment in Innovation, Stability, and Sustainable Growth
DuPont de Nemours, Inc. (NYSE: DD) commonly known as DuPont, headquartered in Wilmington, Delaware, is an American multinational chemical company that was founded in 1802 by Éleuthère Irénée du Pont de Nemours, a French American chemist and industrialist. Over the years, DuPont has evolved into a major supplier of technology-based materials and solutions, offering a diverse range of products across various industries, including adhesives, advanced printing solutions, animal nutrition, construction materials, biomaterials, electronic solutions, fabrics, fibers, nonwovens, food and beverage ingredients, industrial films, medical devices, and resins.
Retail Investors vs Wall Street: Who’s Winning the Battle for Small-Cap Dominance in 2025?
In 2025, financial markets are witnessing a fascinating tug-of-war: retail investors—empowered by mobile platforms and social media—are increasingly challenging Wall Street’s dominance, especially in the realm of penny stocks, micro-cap companies, and small-cap investment ideas.